SCHEMBL5634697

SCHEMBL5634697

N#CC(=Cc1c(-c2ccc(C#N)cc2)[nH]c2ccccc12)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.55
HPGD P15428 2/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.48
PTGS2 P35354 4/20 0.46
CYP19A1 P11511 1/20 0.43
PIK3CA P42336 1/20 0.41
MTOR P42345 1/20 0.41
PIK3CG P48736 1/20 0.41
HTR6 P50406 1/20 0.39
KIF20A O95235 1/20 0.38
TDO2 P48775 1/20 0.38
POLB P06746 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PKM P14618 2/20 0.38
MAP2 P11137 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5634694 1.00 MAPT (0.55) MAPTHPGDMEN1KMT2AALDH1A1
SCHEMBL5636256 0.94 MAPT (0.60) MAPTHPGDMEN1KMT2AALDH1A1
SCHEMBL5636258 0.94 MAPT (0.60) MAPTHPGDMEN1KMT2AALDH1A1
SCHEMBL5635478 0.91 ALDH1A1 (0.65) MAPTHPGDMEN1KMT2AALDH1A1
SCHEMBL5635476 0.91 ALDH1A1 (0.65) MAPTHPGDMEN1KMT2AALDH1A1
SCHEMBL5635333 0.91 MAPT (0.62) MAPTHPGDMEN1KMT2AALDH1A1
SCHEMBL5636618 0.84 MAPT (0.56) MAPTHPGDMEN1KMT2AALDH1A1
SCHEMBL5636621 0.84 MAPT (0.56) MAPTHPGDMEN1KMT2AALDH1A1
SCHEMBL5635857 0.83 MAPT (0.62) MAPTHPGDMEN1KMT2AALDH1A1
SCHEMBL5635860 0.83 MAPT (0.62) MAPTHPGDMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010559-A1 Indole derivatives for use as chemical uncoupler NOVO NORDISK A/S (DK) 2007-01-11 US claimed
US-20070010559-A1 Indole derivatives for use as chemical uncoupler NOVO NORDISK A/S (DK) 2007-01-11 US disclosed
EP-1689710-A1 INDOLE DERIVATIVES FOR USE AS CHEMICAL UNCOUPLER NOVO NORDISK A/S (DK) 2006-08-16 EP disclosed
WO-2005051908-A1 INDOLE DERIVATIVES FOR USE AS CHEMICAL UNCOUPLER NOVO NORDISK A/S (DK) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010559-A1 Indole derivatives for use as chemical uncoupler GPR119, IDO2, IDO1 MAPT 4316/4885HPGD 841/4885MEN1 4192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.